UnknownNot Applicable

Effectiveness of fESWT in the Treatment of CTS

Austria40 participantsStarted 2019-04-24

Plain-language summary

The carpal tunnel syndrome (CTS) is the most common entrapment neuropathy in the general population.The focus extracorporeal shock wave (fEWST) is a non invasive treatment for various diseases. FESWT is new and potential treatment for peripheral nerve entrapment/ peripheral neuropathy . But there is still little known about the effects and long term effects of fESWT in the treatment of CTS.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- mild to moderate CTS verified by nerve conduction velocity Exclusion Criteria: * metabolic diseases * blood clotting problems * systemic diseases * polyneuropathy * chemotherapy during the study * corticosteroid therapy * use of anticoagulation * history of trauma/surgery or nerve lesion of the teated extremity * CTS surgery on the affected hand * ICD/ pacemaker implantation * other therapy for the affected hand during the study * acute inflammation or infections * severe mental illnesses/psychiatric diseases * severe neurological diseases

What they're measuring

VAS

Timeframe: baseline, 3th,12th and 24th weeks after treatment

Trial details

NCT IDNCT04302909

SponsorMedical University of Vienna

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-05

Contact for this trial

Christina Gesslbauer, Dr.

0043 40040043330 christina.gesslbauer@meduniwien.ac.at

View on ClinicalTrials.gov More Carpal Tunnel Syndrome trials